Neoadjuvant Therapy of Colorectal Liver Metastases: Lessons Learned from Clinical Trials

被引:14
|
作者
Brouquet, Antoine [1 ]
Nordlinger, Bernard [1 ]
机构
[1] Univ Versailles St Quentin Yvelines, Hop Ambroise Pare, AP HP, Dept Digest & Oncol Surg, Versailles, France
关键词
colorectal cancer; liver metastases; chemotherapy; OXALIPLATIN-BASED CHEMOTHERAPY; MULTICENTER RANDOMIZED-TRIAL; HEPATIC ARTERIAL INFUSION; LONG-TERM SURVIVAL; PHASE-III TRIAL; PREOPERATIVE CHEMOTHERAPY; SURGICAL RESECTION; 1ST-LINE TREATMENT; PATHOLOGICAL RESPONSE; FOLINIC ACID;
D O I
10.1002/jso.21657
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Neoadjuvant chemotherapy is increasingly used to improve outcome in patients with colorectal liver metastases (CLM). In patients with unresectable CLM, recent clinical trials evaluate the ability of chemotherapy to increase the resectability rate. In patients with resectable CLM, the objective is to decrease the risk of recurrence after hepatectomy that still remains elevated despite the improvement of the surgical technique. A multidisciplinary approach of patients with CLM is desirable whatever the initial status of resectability. J. Surg. Oncol. 2010; 102: 932-936. (C) 2010 Wiley-Liss, Inc.
引用
收藏
页码:932 / 936
页数:5
相关论文
共 50 条
  • [21] Lessons Learned: Clinical Trials and Operations
    Evans, S.
    MEDICAL PHYSICS, 2016, 43 (06) : 3790 - 3790
  • [22] Systematic Review of Randomized and Nonrandomized Trials of the Clinical Response and Outcomes of Neoadjuvant Systemic Chemotherapy for Resectable Colorectal Liver Metastases
    Terence C. Chua
    Akshat Saxena
    Winston Liauw
    Adel Kokandi
    David L. Morris
    Annals of Surgical Oncology, 2010, 17 : 492 - 501
  • [23] Systematic Review of Randomized and Nonrandomized Trials of the Clinical Response and Outcomes of Neoadjuvant Systemic Chemotherapy for Resectable Colorectal Liver Metastases
    Chua, Terence C.
    Saxena, Akshat
    Liauw, Winston
    Kokandi, Adel
    Morris, David L.
    ANNALS OF SURGICAL ONCOLOGY, 2010, 17 (02) : 492 - 501
  • [24] Colorectal Liver Metastases: The Effect of Response to Neoadjuvant Therapy on Margin Status and Outcomes
    Chandra, Pratik
    Song, Yi
    Seier, Kenneth
    Gonen, Mithat
    Soares, Kevin C.
    Wei, Alice C.
    Kingham, T. P.
    Jarnagin, William R.
    D'angelica, Michael I.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2024, 239 (05) : S275 - S275
  • [25] Changes in the Use of Neoadjuvant Therapy for Colorectal Liver Metastases: Time Trends and Prognosis
    Wattley, Lindsey J.
    Yoder, Lauren
    Wilson, Gregory C.
    Hanseman, Dennis
    Sussman, Jeffrey Jay
    Ahmad, Syed Arif
    Patel, Sameer H.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2020, 231 (04) : S263 - S263
  • [26] Therapeutic Roles of Curcumin: Lessons Learned from Clinical Trials
    Gupta, Subash C.
    Patchva, Sridevi
    Aggarwal, Bharat B.
    AAPS JOURNAL, 2013, 15 (01): : 195 - 218
  • [27] Lessons Learned from HIV Vaccine Clinical Efficacy Trials
    Day, Tracey A.
    Kublin, James G.
    CURRENT HIV RESEARCH, 2013, 11 (06) : 441 - 449
  • [28] Therapeutic Roles of Curcumin: Lessons Learned from Clinical Trials
    Subash C. Gupta
    Sridevi Patchva
    Bharat B. Aggarwal
    The AAPS Journal, 2013, 15 : 195 - 218
  • [29] Clinical trials and novel pathogens: Lessons learned from SARS
    Muller, MP
    McGeer, A
    Straus, SE
    Hawryluck, L
    Gold, WL
    EMERGING INFECTIOUS DISEASES, 2004, 10 (03) : 389 - 394
  • [30] Concise Review: Lessons Learned From Clinical Trials of Gene Therapy in Monogenic Immunodeficiency Diseases
    Williams, David A.
    Thrasher, Adrian J.
    STEM CELLS TRANSLATIONAL MEDICINE, 2014, 3 (05) : 636 - 642